
Drug Delays Arthritis Onset by 4 Years in At-Risk Patients
Scientists discovered that a single year of treatment with abatacept can delay rheumatoid arthritis development by up to four years, even after stopping the medication. The breakthrough offers hope to 400,000 UK patients living with the painful autoimmune condition.



